Definition of primary immunodeficiency in 2011: A "trialogue" among friends

Annals of the New York Academy of Sciences

Volumn 1238, Issue 1, 2011, Pages 1-6

  Conley, Mary Ellen ^a   Notarangelo, Luigi D ^b   Casanova, Jean Laurent ^c,d  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Autoinflammatory disorders; Inborn errors of innate immunity; Population genetics

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; GENE SEQUENCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION; INHERITANCE; INNATE IMMUNITY; NOMENCLATURE; PHENOTYPE; PRIMARY IMMUNODEFICIENCY;

EID: 82555192897     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06212.x     Document Type: Article

References (26)

1. Fudenberg, H., R.A. Good, H.C. Goodman, et al. 1971. Primary immunodeficiencies: Report of a World Health Organization Committee. Pediatrics 47: 927-946.
2. Bruton, O.C. 1952. Agammaglobulinemia. Pediatrics 9: 722-728.
3. Donahue, W.L. 1953. Alymphocytosis. Pediatrics 11: 129-139.
4. Kostmann, R. 1956. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr. Suppl. 45: 1-78.
5. Labecki, T.D. 1957. Low resistance syndrome; clinical and laboratory impressions. Antibiot. Annu. 5: 768-773.
6. Martin, C.M., E. Bronstein & S. Dray. 1957. Agammaglobulinemia: clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 47: 533-543.
7. Bergsma, D. & R.A. Good (Eds). 1968. Immunologic Deficiency Diseases in Man. Vol. 4. National Foundation-March of Dimes. New York.
8. Holmes, B., P.G. Quie, D.B. Windhorst & R.A. Good. 1966. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1: 1225-1228.
9. Klemperer, M.R., H.C. Woodworth, F.S. Rosen & K.F. Austen. 1966. Hereditary deficiency of the second component of complement (C'2) in man. J. Clin. Invest. 45: 880-890.
10. Notarangelo, L.D. & J.L. Casanova. 2009. Primary immunodeficiencies: increasing market share. Curr. Opin. Immunol. 21: 461-465.
11. Pessach, I., J. Walter & L.D. Notarangelo. 2009. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr. Res. 65: 3R-12R.
12. Cairns, J. 1997. Matters of Life and Death. Princeton University Press. Princeton, NJ. p 257.
13. Casanova, J.L. & L. Abel. 2005. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202: 197-201.
14. The Holy Bible, New American Catholic Edition. 1961. Benzinger Brothers, Inc. New York.
15. Sorensen, T.I., G.G. Nielsen, P.K. Andersen & T.W. Teasdale. 1988. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318: 727-732.
16. Alcaïs, A., L. Quintana-Murci, D.S. Thaler, et al. 2010. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann. N.Y. Acad. Sci. 1214: 18-33.
17. Bousfiha, A., C. Picard, S. Boisson-Dupuis, et al. 2010. Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 135: 204-209.
18. Casanova, J.L. & L. Abel. 2007. Primary immunodeficiencies: a field in its infancy. Science 317: 617-619.
19. Barreiro, L.B. & L. Quintana-Murci. 2010. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 11: 17-30.
20. Quintana-Murci, L. & L.B. Barreiro. 2010. The role played by natural selection on Mendelian traits in humans. Ann. N.Y. Acad. Sci. 1214: 1-17.
21. Fine, P.E. 1993. Herd immunity: history, theory, practice. Epidemiol. Rev. 15: 265-302.
22. Snowden, F.M. 2008. Emerging and reemerging diseases: a historical perspective. Immunol. Rev. 225: 9-26.
23. Arkwright, P.D. & A.R. Gennery. 2011. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann. N.Y. Acad. Sci. 1238: 7-14.
24. Rieux-Laucat, F., F. Le Deist, C. Hivroz, et al. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349.
25. Fisher, G.H., F.J. Rosenberg, S.E. Straus, et al. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
26. Crow, Y.J. 2011. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N.Y. Acad. Sci. 1238: 91-98.